Desilylative activation of TMSCN in chemoselective Strecker-Ugi type reaction: functional fused imidazoles as building blocks as an entry route to annulated purines

被引:27
作者
Guchhait, Sankar K. [1 ]
Chaudhary, Vikas [1 ]
机构
[1] NIPER, Dept Med Chem, Mohali 160062, Punjab, India
关键词
ADENOSINE RECEPTOR ANTAGONISTS; ONE-POT; DERIVATIVES; INHIBITORS; WATER; GENERATION; BASE; ACID;
D O I
10.1039/c4ob00882k
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A pathway of desilylative activation of TMSCN as a functional isonitrile equivalent, and DABCO-THF as an appropriate system for activation in a chemoselective Strecker-Ugi type reaction, has rendered ethyl glyoxalate and various heterocyclic-2-amidines as feasible substrates, and afforded the successful synthesis of 3-amino-2-carboxyethyl substituted fused imidazoles as useful building blocks. This class of functional scaffold has provided, via construction of the fused pyrimidinone motif, the synthesis of biologically important C8-N9 annulated purines, adenines and their oxo/thio analogs. This new approach is convenient and flexible for the preparation of versatile purine-condensed heterocycles.
引用
收藏
页码:6694 / 6705
页数:12
相关论文
共 37 条
[1]   A novel class of orally active non-peptide bradykinin B2 receptor antagonists.: 1.: Construction of the basic framework [J].
Abe, Y ;
Kayakiri, H ;
Satoh, S ;
Inoue, T ;
Sawada, Y ;
Imai, K ;
Inamura, N ;
Asano, M ;
Hatori, C ;
Katayama, A ;
Oku, T ;
Tanaka, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) :564-578
[2]   Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity [J].
Ahn, HS ;
Bercovici, A ;
Boykow, G ;
Bronnenkant, A ;
Chackalamannil, S ;
Chow, J ;
Cleven, R ;
Cook, J ;
Czarniecki, M ;
Domalski, C ;
Fawzi, A ;
Green, M ;
Gundes, A ;
Ho, G ;
Laudicina, M ;
Lindo, N ;
Ma, K ;
Manna, M ;
McKittrick, B ;
Mirzai, B ;
Nechuta, T ;
Neustadt, B ;
Puchalski, C ;
Pula, K ;
Silverman, L ;
Smith, E ;
Stamford, A ;
Tedesco, RP ;
Tsai, HG ;
Tulshian, D ;
Vaccaro, H ;
Watkins, RW ;
Weng, XY ;
Witkowski, JT ;
Xia, Y ;
Zhang, HT .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) :2196-2210
[3]   New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Preti, D ;
Tabrizi, MA ;
Fruttarolo, F ;
Romagnoli, R ;
Zaid, NA ;
Moorman, AR ;
Merighi, S ;
Varani, K ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (14) :4697-4701
[4]   An efficient one-pot synthesis of 6-alkoxy-8,9-dialkylpurines via reaction of 5-amino-4-chloro-6-alkylaminopyrimidines with N,N-dimethylalkaneamides and alkoxide ions [J].
Baraldi, PG ;
Broceta, AU ;
de las Infantas, MJP ;
Mochun, JJD ;
Espinosa, A ;
Romagnoli, R .
TETRAHEDRON, 2002, 58 (38) :7607-7611
[5]   N-Fused Imidazoles As Novel Anticancer Agents That Inhibit Catalytic Activity of Topoisomerase IIα and Induce Apoptosis in G1/S Phase [J].
Baviskar, Ashish T. ;
Madaan, Chetna ;
Preet, Ranjan ;
Mohapatra, Purusottam ;
Jain, Vaibhav ;
Agarwal, Amit ;
Guchhait, Sankar K. ;
Kundu, Chanakya N. ;
Banerjee, Uttam C. ;
Bharatam, Prasad V. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (14) :5013-5030
[6]   ANTIINFLAMMATORY ACTIVITY OF SUBSTITUTED 6-HYDROXYPYRIMIDO[2,1-F]PURINE-2,4,8(1H,3H,9H)-TRIONES - ATYPICAL NONSTEROIDAL ANTIINFLAMMATORY AGENTS [J].
BLYTHIN, DJ ;
KAMINSKI, JJ ;
DOMALSKI, MS ;
SPITLER, J ;
SOLOMON, DM ;
CONN, DJ ;
WONG, SC ;
VERBIAR, LL ;
BOBER, LA ;
CHIU, PJS ;
WATNICK, AS ;
SIEGEL, MI ;
HILBERT, JM ;
MCPHAIL, AT .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (06) :1099-1113
[7]   Intramolecular Direct C-H Arylation Approach to Fused Purines. Synthesis of Purino[8,9-f]phenanthridines and 5,6-Dihydropurino[8,9-a]isoquinolines [J].
Cerna, Igor ;
Pohl, Radek ;
Klepetarova, Blanka ;
Hocek, Michal .
JOURNAL OF ORGANIC CHEMISTRY, 2010, 75 (07) :2302-2308
[8]   Rapid synthesis of 3-amino-imidazopyridines by a microwave-assisted four-component coupling in one pot [J].
DiMauro, Erin F. ;
Kennedy, Joseph M. .
JOURNAL OF ORGANIC CHEMISTRY, 2007, 72 (03) :1013-1016
[9]   Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA-α2/α3 binding site agonists for the treatment of anxiety disorders [J].
Goodacre, SC ;
Street, LJ ;
Hallett, DJ ;
Crawforth, JM ;
Kelly, S ;
Owens, AP ;
Blackaby, WP ;
Lewis, RT ;
Stanley, J ;
Smith, AJ ;
Ferris, P ;
Sohal, B ;
Cook, SM ;
Pike, A ;
Brown, N ;
Wafford, KA ;
Marshall, G ;
Castro, JL ;
Atack, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) :35-38
[10]   Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist [J].
Griffith, David A. ;
Hadcock, John R. ;
Black, Shawn C. ;
Iredale, Philip A. ;
Carpino, Philip A. ;
DaSilva-Jardine, Paul ;
Day, Robert ;
DiBrino, Joseph ;
Dow, Robert L. ;
Landis, Margaret S. ;
O'Connor, Rebecca E. ;
Scott, Dennis O. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :234-237